免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

FluChip-8G 間接流感A+B檢測試劑

K 號:K182513 · 2019-04-22

申請人Indevr, Inc.
決定日期2019-04-22
產品代碼OZE
諮詢委員會MI (請提供完整的描述文本,以便進行翻譯。)
決定相當於

器材摘要

FluChip-8G Influenza A+B Assay is the device name listed in this FDA 510(k) record. The listed applicant is Indevr, Inc.. It received FDA 510(k) clearance on 2019-04-22 under 510(k) number K182513. The device is classified under product code OZE. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the FluChip-8G Influenza A+B Assay?

FluChip-8G Influenza A+B Assay is a medical device that received FDA 510(k) clearance on 2019-04-22. The listed applicant is Indevr, Inc.. The 510(k) number is K182513.

When did FluChip-8G Influenza A+B Assay receive FDA 510(k) clearance?

FluChip-8G Influenza A+B Assay received FDA 510(k) clearance on 2019-04-22, under 510(k) number K182513.

Who is the listed applicant for FluChip-8G Influenza A+B Assay?

The FDA 510(k) record lists Indevr, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FluChip-8G Influenza A+B Assay?

The FDA product code for FluChip-8G Influenza A+B Assay is OZE.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:OZE)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑